本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

iTeos Therapeutics

7.35
-0.1100-1.47%
盘前7.27-0.0800-1.09%06:42 EDT
成交量:34.39万
成交额:252.73万
市值:2.81亿
市盈率:-2.21
高:7.50
开:7.35
低:7.23
收:7.46
数据加载中...
2025/03/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/05

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/21

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/18

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/18

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

重要事件披露

Form 8-K - Current report
2024/10/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/30

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/16

重要事件披露

Form 8-K - Current report
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/13

重要事件披露

Form 8-K - Current report
2024/05/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/03/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans